Transcription profiling of estrogen target genes in young and old mouse uterus

Experimental Gerontology

Volumn 38, Issue 10, 2003, Pages 1087-1099

  Khalyfa, Abdelnaby ^a   Klinge, Carolyn M ^a   Hall, William C ^a   Zhao, Xuechun ^a   Miller, Marilyn M ^b,c   Wang, Eugenia ^a  

^a University of Louisville School of Medicine   (United States)

^b MCGILL UNIVERSITY   (Canada)

^c National Institute of Aging   (United States)

Author keywords

Aging; Estrogen; Estrogen response elements; Microarray; Mouse; Transcription; Uterus

Indexed keywords

BETA ACTIN; CALCIUM BINDING PROTEIN; CHICKEN OVALBUMIN UPSTREAM PROMOTER TRANSCRIPTION FACTOR; COMPLEMENT COMPONENT C3; ESTROGEN; LACTOFERRIN; NYLON; TESTOSTERONE 17BETA DEHYDROGENASE; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR SP1;

AGED; AGING; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DATA BASE; DNA MICROARRAY; DOWN REGULATION; EPITHELIUM; ESTROGEN RESPONSIVE ELEMENT; FEMALE; GENE EXPRESSION; GENE IDENTIFICATION; GENE TARGETING; GENETIC TRANSCRIPTION; GENOME; MOUSE; MYOBLAST; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROMA; UPREGULATION; UTERUS;

EID: 0142217366     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0531-5565(03)00210-9     Document Type: Article

References (72)

1. Achatz G. Functional domains of the human orphan receptor ARP-1/ COUP-TFII involved in active repression and transrepression. Mol. Cell Biol. 17:1997;4914-4932.
2. Afshari C.A. Perspective: microarray technology, seeing more than spots. Endocrinology. 143:2002;1983-1989.
3. Akcay T., Dincer Y., Kayali R., Colgar U., Oral E., Cakatay U. Effects of hormone replacement therapy on lipid peroxides and oxidation system in postmenopausal women. J. Toxicol. Environ. Health. 59:2000;1-5.
4. Ammanamanchi S., Kim S.J., Sun L.Z., Brattain M.G. Induction of transforming growth factor-beta receptor type II expression in estrogen receptor-positive breast cancer cells through SP1 activation by 5-aza-2'-deoxycytidine. J. Biol. Chem. 273:1998;16527-16534.
5. Bartosiewicz M., Trounstine M., Barker D., Johnston R., Buckpitt A. Development of a toxicological gene array and quantitative assessment of this technology. Arch Biochem. Biophys. 376:2000;66-73.
6. Belisle S., Bellabarba D., Lehoux J.G. On the presence of nonfunctional uterine estrogen receptors in middle-aged and old C57BL/6J mice. Endocrinology. 116:1985;148-153.
7. Belisle S., Bellabarba D., Lehoux J.G. Enhanced inhibition of estrogen receptor nuclear binding in the uterus of aged mice. J. Steroid Biochem. 26:1987;521-526.
8. van den Berg T.K., van Die I., de Lavalette C.R., Dopp E.A., Smit L.D., van der Meide P.H., Tilders F.J., Crocker P.R., Dijkstra C.D. Regulation of sialoadhesin expression on rat macrophages. Induction by glucocorticoids and enhancement by IFN-beta, IFN-gamma, IL-4, and lipopolysaccharide. J. Immunol. 157:1996;3130-3138.
9. Bergman M.D., Karelus K., Felicio L.S., Nelson J.F. Differential effects of aging on estrogen receptor dynamics in hypothalamus, pituitary and uterus of the C57BL/6J mouse. J. Steroid Biochem. 33:1989;1027-1033.
10. Bergman M.D., Karelus K., Felicio L.S., Nelson J.F. Age-related alterations in estrogen receptor dynamics are independent of cycling status in middle-aged C57BL/6J mice. J. Steroid Biochem. Mol. Biol. 38:1991;127-133.
11. Bigsby R.M., Young P.C. Estrogenic effects of the antiprogestin onapristone (ZK98.299) in the rodent uterus. Am. J. Obstet. Gynecol. 171:1994;188-194.
12. Britt K.L., Drummond A.E., Cox V.A., Dyson M., Wreford N.G., Jones M.E., Simpson E.R., Findlay J.K. An age-related ovarian phenotype in mice with targeted disruption of the Cyp 19 (aromatase) gene. Endocrinology. 141:2000;2614-2623.
13. Brown E.O., Sundstrom S.A., Komm B.S., Yi Z., Teuscher C., Lyttle C.R. Progesterone regulation of estradiol-induced rat uterine secretory protein, complement C3. Biol. Reprod. 42:1990;713-719.
14. Burleson M.H., Malarkey W.B., Cacioppo J.T., Poehlmann K.M., Kiecolt-Glaser J.K., Berntson G.G., Glaser R. Postmenopausal hormone replacement: effects on autonomic, neuroendocrine, and immune reactivity to brief psychological stressors. Psychosom. Med. 60:1998;17-25.
15. Carson D.D., DeSouza M.M., Kardon R., Zhou X., Lagow E., Julian J. Mucin expression and function in the female reproductive tract. Hum. Reprod. Update. 4:1998;459-464.
16. Castro-Rivera E., Samudio I., Safe S. Estrogen regulation of cyclin D1 gene expression in ZR-75 breast cancer cells involves multiple enhancer elements. J. Biol. Chem. 15:2001;15.
17. Chambliss K.L., Shaul P.W. Estrogen modulation of endothelial nitric oxide synthase. Endocrinol. Rev. 23:2002;665-686.
18. Chu K., Boutin J.M., Breton C., Zingg H.H. Nuclear orphan receptors COUP-TFII and Ear-2: presence in oxytocin-producing uterine cells and functional interaction with the oxytocin gene promoter. Mol. Cell Endocrinol. 137:1998;145-154.
19. Cilley R.E., Zgleszewski S.E., Chinoy M.R. Fetal lung development: airway pressure enhances the expression of developmental genes. J. Pediatr. Surg. 35:2000;113-118. discussion 119.
20. Clemons M., Goss P. Estrogen and the risk of breast cancer. N. Engl. J. Med. 344:2001;276-285.
21. Crocker P.R., Kelm S., Dubois C., Martin B., McWilliam A.S., Shotton D.M., Paulson J.C., Gordon S. Purification and properties of sialoadhesin, a sialic acid-binding receptor of murine tissue macrophages. Embo J. 10:1991;1661-1669.
22. Diela P., Schulza T., Smolnikara K., Strunckb E., Vollmerc G., Michnaa H. Ability of xeno- and phytoestrogens to modulate expression of estrogen-sensitive genes in rat uterus: estrogenicity profiles and uterotropic activity. J. Steroid Biochem. Mol. Biol. 73:2000;1-10.
23. Feeley K.M., Wells M. Hormone replacement therapy and the endometrium. J. Clin. Pathol. 54:2001;435-440.
24. Fink G., Sumner B.E., McQueen J.K., Wilson H., Rosie R. Sex steroid control of mood, mental state and memory. Clin. Exp. Pharmacol. Physiol. 25:1998;764-775.
25. Grodstein F., Clarkson T.B., Manson J.E. Understanding the divergent data on postmenopausal hormone therapy. N. Engl. J. Med. 348:2003;645-650.
26. Hall W.C. Online Microarray Analysis. 2001;University of Louisville Speed Scientific School, Louisville, KY.
27. Hasty L.A., Lyttle C.R. Progesterone and RU486 regulation of uterine complement C3 after prior induction with estradiol. Biol. Reprod. 47:1992;285-290.
28. Hopert A.C., Beyer A., Frank K., Strunck E., Wunsche W., Vollmer G. Characterization of estrogenicity of phytoestrogens in an endometrial-derived experimental model. Environ. Health Perspect. 106:1998;581-586.
29. Howe R.S., Lee Y.H., Fischkoff S.A., Teuscher C., Lyttle C.R. Glucocorticoid and progestin regulation of eosinophil chemotactic factor and complement C3 in the estrogen-treated rat uterus. Endocrinology. 126:1990;3193-3199.
30. Jager D., Stockert E., Gure A.O., Scanlan M.J., Karbach J., Jager E., Knuth A., Old L.J., Chen Y.-T. Identification of a tissue-specific putative transcription factor in breast tissue by serological screening of a breast cancer library. Cancer Res. 61:2001;2055-2061.
31. Jaiswal Y.K., Kanungo M.S. Expression of actin and myosin heavy chain genes in skeletal, cardiac and uterine muscles of young and old rats. Biochem. Biophys. Res. Commun. 168:1990;71-77.
32. Jefferson W.N., Padilla-Banks E., Newbold R.R. Lactoferrin is an estrogen responsive protein in the uterus of mice and rats. Reprod. Toxicol. 14:2000;103-110.
33. Jonas N.K., Saleh M. The expression of vascular endothelial platelet endothelial cell adhesion molecule-1 is not regulated by IFN-gamma treatment of C6 tumors in vivo. Int. J. Oncol. 17:2000;939-945.
34. Jones E.C. The ageing ovary and its influence on reproductive capacity. J. Reprod. Fertil. Suppl. 12:1970;17-30.
35. Jucker M., Walker L.C., Kuo H., Tian M., Ingram D.K. Age-related fibrillar deposits in brains of C57BL/6 mice. A review of localization, staining characteristics, and strain specificity. Mol. Neurobiol. 9:1994;125-133.
36. Klinge C.M. Role of estrogen receptor ligand and estrogen response element sequence on interaction with chicken ovalbumin upstream promoter transcription factor (COUP-TF). J. Steroid Biochem. Mol. Biol. 71:1999;1-19.
37. Klinge C.M. Estrogen receptor interaction with co-activators and co-repressors. Steroids. 65:2000;227-251.
38. Klinge C.M. Estrogen receptor interaction with estrogen response elements. Nucleic Acids Res. 29:2001;2905-2919.
39. Klinge C.M., Silver B.F., Driscoll M.D., Sathya G., Bambara R.A., Hilf R. COUP-TF interacts with estrogen receptor, binds to estrogen response elements and half-sites, and modulates estrogen-induced gene expression. J. Biol. Chem. 272:1997;31465-31474.
40. Kushner P.J., Agard D., Feng W.J., Lopez G., Schiau A., Uht R., Webb P., Greene G. Oestrogen receptor function at classical and alternative response elements. Novartis Found Symp. 230:2000;20-26. discussion 27-40.
41. Lacey J.V. Jr, Mink P.J., Lubin J.H., Sherman M.E., Troisi R., Hartge P., Schatzkin A., Schairer C. Menopausal hormone replacement therapy and risk of ovarian cancer. Jama. 288:2002;334-341.
42. Lakhani S.R., O'Hare M.J., Ashworth A. Profiling familial breast cancer. Nat. Med. 7:2001;408-410.
43. Lamberts S.W., van den Beld A.W., van der Lely A.J. The endocrinology of aging. Science. 278:1997;419-424.
44. Leiva M.C., Lyttle C.R., Jellinck P.H. Complement C3 synthesis, peroxidase activity and eosinophil chemotaxis in the rat uterus: effect of estradiol and testosterone. Mol. Cell Endocrinol. 81:1991;105-111.
45. Levin E.R. Cellular functions of plasma membrane estrogen receptors. Steroids. 67:2002;471-475.
46. von der Mark K., Mollenhauer J. Annexin V interactions with ollagen. Cell Mol. Life Sci. 53:1997;539-545.
47. Miller M.M., Joshi D., Billiar R.B., Nelson J.F. Loss of LH-RH neurons in the rostral forebrain of old female C57BL/6J mice. Neurobiol. Aging. 11:1990;217-221.
48. Motonaga K., Itoh M., Hachiya Y., Endo A., Kato K., Ishikura H., Saito Y., Mori S., Takashima S., Goto Y. Age related expression of Werner's syndrome protein in selected tissues and coexpression of transcription factors. J. Clin. Pathol. 55:2002;195-199.
49. Nelson H.D., Humphrey L.L., Nygren P., Teutsch S.M., Allan J.D. Postmenopausal hormone replacement therapy: scientific review. Jama. 288:2002;872-881.
50. Palmieri D., Watson J.M., Rinehart C.A. Age-related expression of PEDF/EPC-1 in human endometrial stromal fibroblasts: implications for interactive senescence. Exp. Cell Res. 247:1999;142-147.
51. Qiu Y., Krishnan V., Piereira F.A., Tsai S.Y., Tsai M.-J. Chicken ovalbumin upstream promoter-transcription factors and their regulation. J. Steroid Biochem. Mol. Biol. 56:1996;81-85.
52. Razandi M., Pedram A., Park S.T., Levin E.R. Proximal events in signaling by plasma membrane estrogen receptors. J. Biol. Chem. 278:2003;2701-2712.
53. Rodan G.A., Martin T.J. Therapeutic approaches to bone diseases. Science. 289:2000;1508-1514.
54. Rossouw J., Anderson G., Prentice R., LaCroix A., Kooperberg C., Stefanick M., Jackson R., Beresford S., Howard B., Johnson K. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. Jama. 288:2002;321-333.
55. Russo-Marie F. Annexin V and phospholipid metabolism. Clin. Chem. Lab. Med. 37:1999;287-291.
56. Sabbah M., Courilleau D., Mester J., Redeuilh G. Estrogen induction of the cyclin D1 promoter: involvement of a cAMP response-like element. Proc. Natl. Acad. Sci. USA. 96:1999;11217-11222.
57. Semov A., Marcotte R., Semova N., Ye X., Wang E. Microarray analysis of E-box binding-related gene expression in young and replicatively senescent human fibroblasts. Anal. Biochem. 302:2002;38-51.
58. Soriero A.A., Talbert G.B. The effect of estrogen on protein and RNA concentration and on de novo synthesis of RNA in the uterus of aging ovariectomized mice. J. Gerontol. 30:1975;264-268.
59. Stroup D., Crestani M., Chiang J.Y.L. Orphan receptors chicken ovalbumin upstream promoter transcription factor II (COUP-TFII) and Retinoid X Receptor (RXR) activate and bind the rat cholesterol 7-hydroxylase gene (CYP7A). J. Biol. Chem. 272:1997;9833-9839.
60. Strunck E., Stemmann N., Hopert A., Wunsche W., Frank K., Vollmer G. Relative binding affinity does not predict biological response to xenoestrogens in rat endometrial adenocarcinoma cells. J. Steroid Biochem. Mol. Biol. 74:2000;73-81.
61. Sundstrom S.A., Komm B.S., Ponce-de-Leon H., Yi Z., Teuscher C., Lyttle C.R. Estrogen regulation of tissue-specific expression of complement C3. J. Biol. Chem. 264:1989;16941-16947.
62. Suzuki T., Takahashi K., Darnel A.D., Moriya T., Murakami O., Narasaka T., Takeyama J., Sasano H. Chicken ovalbumin upstream promoter transcription factor II in the human adrenal cortex and its disorders. J. Clin. Endocrinol. Metabol. 85:2000;2752-2757.
63. Suzuki Y., Tsunoda T., Sese J., Taira H., Mizushima-Sugano J., Hata H., Ota T., Isogai T., Tanaka T., Nakamura Y., et al. Identification and characterization of the potential promoter regions of 1031 kinds of human genes. Genome Res. 11:2001;677-684.
64. Teng C.T. Lactoferrin gene expression and regulation: an overview. Biochem. Cell Biol. 80:2002;7-16.
65. Vollmer G., Ellerbrake N., Hopert A.C., Knauthe R., Wunsche W., Knuppen R. Extracellular matrix induces hormone responsiveness and differentiation in RUCA-I rat endometrial adenocarcinoma cells. J. Steroid Biochem. Mol. Biol. 52:1995;259-269.
66. Vollmer G., Hopert A.C., Ellerbrake N., Wunsche W., Knuppen R. Fibronectin is an estrogen-repressed protein in RUCA-I rat endometrial adenocarcinoma cells. J. Steroid Biochem. Mol. Biol. 54:1995;131-139.
67. Welsh J.B., Zarrinkar P.P., Sapinoso L.M., Kern S.G., Behling C.A., Monk B.J., Lockhart D.J., Burger R.A., Hampton G.M. Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer. Proc. Natl. Acad. Sci. USA. 98:2001;1176-1181.
68. Wingender E., Chen X., Fricke E., Geffers R., Hehl R., Liebich I., Krull M., Matys V., Michael H., Ohnhauser R., et al. The TRANSFAC system on gene expression regulation. Nucleic Acids Res. 29:2001;281-283.
69. Wise P.M., Smith M.J., Dubal D.B., Wilson M.E., Krajnak K.M., Rosewell K.L. Neuroendocrine influences and repercussions of the menopause. Endocrinol. Rev. 20:1999;243-248.
70. Xie W., Duan R., Chen I., Samudio I., Safe S. Transcriptional activation of thymidylate synthase by 17beta-estradiol in MCF-7 human breast cancer cells. Endocrinology. 141:2000;2439-2449.
71. Xie W., Duan R., Safe S. Activation of adenosine deaminase in MCF-7 cells through IGF-estrogen receptor alpha crosstalk. J. Mol. Endocrinol. 26:2001;217-228.
72. Zeitoun K., Takayama K., Michael M.D., Bulun S.E. Stimulation of aromatase P450 promoter (II) activity in endometriosis and its inhibition in endometrium are regulated by competitive binding of steroidogenic ractor-1 and chicken ovalbumin upstream promoter transcription factor to the same cis-acting element. Mol. Endocrinol. 13:1999;239-253.